...
首页> 外文期刊>Indian journal of dermatology, venereology and leprology >Ultrasound liver elastography for the detection of liver fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy: A cross-sectional study
【24h】

Ultrasound liver elastography for the detection of liver fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy: A cross-sectional study

机译:超声肝弹性术,用于检测肝纤维化患者牛皮癣和活性关节炎长期甲氨蝶呤治疗:横截面研究

获取原文

摘要

Background: Long-term low-dose methotrexate therapy is associated with liver fibrosis. Although liver biopsy is the gold standard for detecting fibrosis, it is an invasive procedure associated with morbidity and mortality risks. Hence noninvasive imaging techniques such as transient elastography (TE) and shear wave elastography (SWE) have been studied to measure liver stiffness. Aims: To assess the utility of TE and SWE in detecting fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy. Methods: A cross-sectional prospective study was undertaken on 54 patients with psoriasis and reactive arthritis who had received ≥1.5 g of methotrexate. Various clinical and biochemical [fibrosis 4 index (FIB4), aspartate-transaminase-to-platelet ratio index (APRI)] parameters were calculated and liver stiffness measurement (LSM) was done with TE and SWE. The degree of steatosis was measured using controlled attenuation parameter (CAP). Liver biopsy was done when indicated and was interpreted by a pathologist blinded to clinical and imaging results. Results: Fifty four patients with a mean age of 40.3 years and a male-to-female ratio of 5:1 were included. The mean cumulative methotrexate dose was 3.04 g. The median FIB4, APRI, and gamma-glutamyl transpeptidase-to-platelet ratio values were 0.75, 0.23, and 0.15, respectively. The median LSM for TE and SWE was 5.3 and 7.32 kPa, respectively. SWE and TE showed a weak positive correlation (r = 0.26, P = 0.053). The mean CAP was 217 dB/m (area under the receiver operating characteristic = 0.70). In the 19 of 26 cases whose liver biopsies could be assessed, only 4 (21%) showed F1 fibrosis (Ishak staging). The median LSM on SWE was significantly higher in patients with a cumulative methotrexate dose ≥ 4 g when compared with those with a dose 4 g (9.85 vs 7.1, P = 0.02). Other parameters did not correlate with TE and SWE. Limitations: The small sample size and the low number of cases with significant fibrosis on histopathology were the major limitations of this study. Conclusion: Histologically detectable LF is uncommon in patients with psoriasis and reactive arthritis on long-term methotrexate therapy. Both TE and SWE are good at detecting the absence of fibrosis in these patients. In our study, SWE and TE values did not correlate with clinical, biochemical, or histopathological parameters.
机译:背景:长期低剂量甲氨蝶呤治疗与肝纤维化有关。虽然肝脏活检是检测纤维化的金标准,但它是一种与发病率和死亡率风险相关的侵入性手续。因此,已经研究了非侵入性成像技术,例如瞬态弹性显影(TE)和剪切波弹性显影(SWE)以测量肝硬化。目的:评估TE和SWE在长期甲氨蝶呤治疗方面检测牛皮癣患者纤维化的效用。方法:对54例牛皮癣和活性关节炎患者进行了横截面前瞻性研究,患有≥1.5g甲氨蝶呤。各种临床和生物化学[纤维化4指数(FIB4),天冬氨酸 - 转氨酶对血小板比率指数(APRI)]参数进行了计算,并用TE和SWE完成肝硬化测量(LSM)。使用受控衰减参数(盖子)测量脂肪变性程度。当指出时,肝活组织检查是通过盲目的病理学家解释为临床和成像结果。结果:五十四名患有40.3岁的平均年龄,男性与女性比例为5:1。平均累积甲氨蝶呤剂量为3.04克。中值FIB4,APRI和γ-谷氨酸二肽酶 - 血小板比值分别为0.75,0.23和0.15。 TE和SWE的中位LSM分别为5.3和7.32 kPa。 SWE和TE显示出较弱的正相关(r = 0.26,p = 0.053)。平均帽是217db / m(接收器下的区域操作特性= 0.70)。在肝脏活组织检查可以评估的26例中,只有4(21%)显示F1纤维化(ISHAK分期)。与剂量<4g(9.85 Vs 7.1,P = 0.02)相比,SWE上的中位LSM在SWE上的中位LSM在累积甲氨蝶呤剂量≥4g的患者中显着高。其他参数与TE和SWE没有相关。局限性:小样本大小和具有显着纤维化的少数病例组织病理学是本研究的主要局限性。结论:在长期甲氨蝶呤治疗牛皮癣和反应性关节炎患者中,组织学可检测的LF罕见。 Te和Swe都擅长检测这些患者的纤维化。在我们的研究中,SWE和TE值与临床,生物化学或组织病理学参数无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号